PDF herunterladen
The Journal of Hip Surgery 2023; 07(01): 035-042
DOI: 10.1055/s-0043-1764438
Original Article

Outcomes of Core Decompression and Bone Marrow Aspirate Concentrate Injection for Osteonecrosis of the Femoral Head

Oren I. Feder 
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Matthew Galetta
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Richard Iorio
2   Department of Orthopaedic Surgery, Brigham Health, Boston, Massachusetts
,
Ran Schwarzkopf
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Thomas Einhorn
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Without intervention, 80% of hips with osteonecrosis (ON) will progress. Core decompression (CD) has shown favorable results (60–80% survivorship) in early stage ON, and recently, bone marrow aspirate concentration (BMAC) injection into the decompressed femoral head has been proposed to stimulate healing of the necrotic lesion and improve outcomes and survivorship. We reviewed the clinical and radiographic outcomes of 51 Steinberg stage 2 hips in 31 patients who underwent CD + BMAC for ON with a minimum of 1 year follow-up. We evaluated preoperative visual analog pain scores (VAS), Steinberg stage based on radiographs, and Kerboul angle as measured on magnetic resonance imaging. Clinical outcomes were reported as a change in VAS at final follow-up, hip and disability osteoarthritis score for joint replacements (HOOS, JR) score at final follow-up, advancement in Steinberg stage based on radiographs, or decision to proceed with total hip arthroplasty (THA). At an average of 27 months, VAS scores improved from 7 to 2.3 (p < 0.001). In total, 38 of 51 hips (75%) had stable radiographs, while 13 of 51 hips (25%) progressed radiographically or proceeded to THA. The average HOOS JR score in patients at final follow-up was 87.5, indicating excellent hip function. Of the patients that went on to THA, all were preoperative Steinberg stage 2C and the preoperative Kerboul angle in this cohort was 241, compared with 163 in those hips that did not go on to THA (p < 0.001). In preoperative hips that were Steinberg stage 2B or less, there was no advancement in the radiographic stage, whereas 67% of patients with preoperative stage 2C hips progressed (p < 0.001). CD + BMAC significantly improves pain and helps prevent the progression of ON when performed on patients in whom ON is classified as Steinberg stage 2B or less or in whom the Kerboul angle is 180 or less. Level of evidence was level III.

Keywords

core decompression - bone marrow aspirate concentration - hip arthroplasty - osteonecrosis - avascular necrosis


Publikationsverlauf

Eingereicht: 17. April 2022

Angenommen: 05. Dezember 2022

Artikel online veröffentlicht:
16. März 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Banerjee S. . Kapadia BH, Jauregui JJ, Cherian JJ, Mont MA, Osteonecrosis: Berlin, Heidelberg: Springer; 2014.
  • 2 Guerado E, Caso E. The physiopathology of avascular necrosis of the femoral head: an update. Injury 2016; 47 (Suppl (Suppl. 06) S16-S26
    CrossrefPubMedGoogle Scholar
  • 3 Mont MA, Carbone JJ, Fairbank AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res 1996; ;( (324) 169-178
    CrossrefPubMedGoogle Scholar
  • 4 Ohzono K, Saito M, Takaoka K. et al. Natural history of nontraumatic avascular necrosis of the femoral head. J Bone Joint Surg Br 1991; 73 (01) 68-72
    CrossrefPubMedGoogle Scholar
  • 5 Mankin HJ. Nontraum atic necrosis of bone (osteonecrosis). N Engl J Med 1992; 326 (22) 1473-1479
    CrossrefPubMedGoogle Scholar
  • 6 Yu X, Zhang D, Chen X, Yang J, Shi L, Pang Q. Effectiveness of various hip preservation treatments for non-traumatic osteonecrosis of the femoral head: a network meta-analysis of randomized controlled trials. J Orthop Sci 2018; 23 (02) 356-364
    CrossrefPubMedGoogle Scholar
  • 7 Boontanapibul K, Steere JT, Amanatullah DF, Huddleston III JI, Maloney WJ, Goodman SB. Diagnosis of osteonecrosis of the femoral head: too little, too late, and independent of etiology. J Arthroplasty 2020; 35 (09) 2342-2349
    CrossrefPubMedGoogle Scholar
  • 8 Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update. J Bone Joint Surg Am 2015; 97 (19) 1604-1627
    CrossrefPubMedGoogle Scholar
  • 9 Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 2006; 88 (05) 1117-1132
    PubMedGoogle Scholar
  • 10 Wang C, Wang Y, Meng HY. et al. Application of bone marrow mesenchymal stem cells to the treatment of osteonecrosis of the femoral head. Int J Clin Exp Med 2015; 8 (03) 3127-3135
    PubMedGoogle Scholar
  • 11 Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 2002; ;( (405) 14-23
    CrossrefPubMedGoogle Scholar
  • 12 Gangji V, Hauzeur JP. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique. J Bone Joint Surg Am 2005; 87 Pt 1, Suppl 01 106-112
    PubMedGoogle Scholar
  • 13 Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 2004; 86 (06) 1153-1160
    CrossrefPubMedGoogle Scholar
  • 14 Seng C, Siddiqui MA, Wong KPL. et al. Five-year outcomes of minimally invasive versus open transforaminal lumbar interbody fusion: a matched-pair comparison study. Spine 2013; 38 (23) 2049-2055
    CrossrefPubMedGoogle Scholar
  • 15 Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br 1995; 77 (01) 34-41
    CrossrefPubMedGoogle Scholar
  • 16 Ha YC, Jung WH, Kim JR, Seong NH, Kim SY, Koo KH. Prediction of collapse in femoral head osteonecrosis: a modified Kerboul method with use of magnetic resonance images. J Bone Joint Surg Am 2006; 88 (Suppl (Suppl. 03) 35-40
    PubMedGoogle Scholar
  • 17 Kerboul M, Thomine J, Postel M, Merle d'Aubigné R. The conservative surgical treatment of idiopathic aseptic necrosis of the femoral head. J Bone Joint Surg Br 1974; 56 (02) 291-296
    CrossrefPubMedGoogle Scholar
  • 18 Kunze KN, Sullivan SW, Nwachukwu BU. Updates on management of avascular necrosis using hip arthroscopy for core decompression. Front Surg 2022; 9: 662722
    CrossrefPubMedGoogle Scholar
  • 19 Hozack W, Parvizi J, Bender B. . Surgical Treatment of Hip Arthritis船: Reconstruction, Replacement, and Revision. Saunders/Elsevier, 2010.
  • 20 Ollivier M, Lunebourg A, Abdel MP, Parratte S, Argenson JN. Anatomical findings in patients undergoing total hip arthroplasty for idiopathic femoral head osteonecrosis. J Bone Joint Surg Am 2016; 98 (08) 672-676
    CrossrefPubMedGoogle Scholar
  • 21 Hernigou P, Trousselier M, Roubineau F. et al. Stem cell therapy for the treatment of hip osteonecrosis: a 30-year review of progress. Clin Orthop Surg 2016; 8 (01) 1-8
    CrossrefPubMedGoogle Scholar
  • 22 Scully SP, Aaron RK, Urbaniak JR. Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis. J Bone Joint Surg Am 1998; 80 (09) 1270-1275
    CrossrefPubMedGoogle Scholar
  • 23 Rijnen WH, Gardeniers JW, Buma P, Yamano K, Slooff TJ, Schreurs BW. Treatment of femoral head osteonecrosis using bone impaction grafting. Clin Orthop Relat Res 2003; ;( (417) 74-83
    CrossrefPubMedGoogle Scholar
  • 24 Gangji V, Toungouz M, Hauzeur JP. Stem cell therapy for osteonecrosis of the femoral head. Expert Opin Biol Ther 2005; 5 (04) 437-442
    CrossrefPubMedGoogle Scholar
  • 25 Tabatabaee RM, Saberi S, Parvizi J, Mortazavi SM, Farzan M. Combining concentrated autologous bone marrow stem cells injection with core decompression improves outcome for patients with early-stage osteonecrosis of the femoral head: a comparative study. J Arthroplasty 2015; 30 (09) , Suppl): 11-15
    CrossrefPubMedGoogle Scholar
  • 26 Xian H, Luo D, Wang L. et al. Platelet-rich plasma-incorporated autologous granular bone grafts improve outcomes of post-traumatic osteonecrosis of the femoral head. J Arthroplasty 2020; 35 (02) 325-330
    CrossrefPubMedGoogle Scholar
  • 27 Sen RK, Tripathy SK, Aggarwal S, Marwaha N, Sharma RR, Khandelwal N. Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplasty 2012; 27 (05) 679-686
    CrossrefPubMedGoogle Scholar
  • 28 Song S, Zhu S, Sun C. [Treatment of avascular necrosis of femoral head by periosteal cell transplantation: an experimental study]. Zhonghua Yi Xue Za Zhi 1998; 78 (01) 52-55
    PubMedGoogle Scholar
  • 29 Hauzeur JP, De Maertelaer V, Baudoux E, Malaise M, Beguin Y, Gangji V. Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. Int Orthop 2018; 42 (07) 1429-1435
    CrossrefPubMedGoogle Scholar
  • 30 Martí-Carvajal AJ, Solà I, Agreda-Pérez LH. Treatment for avascular necrosis of bone in people with sickle cell disease. Cochrane Database Syst Rev 2019; 12 (12) CD004344
    PubMedGoogle Scholar
  • 31 Lyman S, Lee YY, Franklin PD, Li W, Mayman DJ, Padgett DE. Validation of the HOOS, JR: a short-form hip replacement survey. Clin Orthop Relat Res 2016; 474 (06) 1472-1482
    CrossrefPubMedGoogle Scholar